All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.

The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

How does COVID-19 infection affect hematopoiesis in MDS?

During the ESH 2nd Translational Research Conference: Erythropoiesis Control and Ineffective Erythropoiesis - From Bench to Bedside, the MDS Hub spoke to Eric Solary, Gustave Roussy, Paris, FR. We asked, How does COVID-19 infection affect hematopoiesis in MDS?

How does COVID-19 infection affect hematopoiesis in MDS?

In the majority of COVID-19 infections, the virus induces an effective antiviral, interferon response. However, for a minority with severe disease, a stress hematopoiesis response is detected, preventing patients from building an appropriate immune response. Patients with MDS could be predisposed to the virus since the hematopoietic response in the severe form of COVID-19 resembles that of acute MDS. For that reason, Solary urges patients to remain cautious and get immunized.

 

Share: